Outpatient Management of Neutropenic Fever: Antibiotics, Growth Factors or Both?
作者： Edward B Rubenstein , Linda S. Elting , Charlotte C. Sun , Kenneth V. I. Rolston
DOI: 10.1007/978-1-4615-5013-6_8
关键词: Risk of infection 、 Absolute neutrophil count 、 Neutropenia 、 Medicine 、 Internal medicine 、 Febrile neutropenia 、 Myelosuppressive Chemotherapy 、 Cancer 、 Intensive care medicine 、 Antibiotics 、 Outpatient management
摘要: The association of neutropenia and infection in patients with cancer receiving myelosuppressive chemotherapy was established over three decades ago by Bodey et al, who demonstrated that the risk began to increase as neutrophil count fell below 1000/mm3 greatest at levels 100/mm3 (Figure 1)1.
springer.com
sci-hub.st 参考文章(36)
R Pettengell, H Gurney, JA Radford, DP Deakin, R James, PM Wilkinson, K Kane, J Bentley, D Crowther, Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial Blood. ,vol. 80, pp. 1430- 1436 ,(1992) , 10.1182/BLOOD.V80.6.1430.BLOODJOURNAL8061430
Gerald L. Mandell, R. Gordon Douglas, John E. Bennett, Principles and Practice of Infectious Diseases ,(1985)
P L Mitchell, B Morland, M C Stevens, G Dick, D Easlea, L C Meyer, C R Pinkerton, Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients. Journal of Clinical Oncology. ,vol. 15, pp. 1163- 1170 ,(1997) , 10.1200/JCO.1997.15.3.1163
J A Talcott, A Whalen, J Clark, P P Rieker, R Finberg, Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. Journal of Clinical Oncology. ,vol. 12, pp. 107- 114 ,(1994) , 10.1200/JCO.1994.12.1.107
Ben E De Pauw, Stanley C Deresinski, Ronald Feld, Elizabeth F Lane-Allman, J Peter Donnelly, Ceftazidime Compared with Piperacillin and Tobramycin for the Empiric Treatment of Fever in Neutropenic Patients with Cancer: A Multicenter Randomized Trial Annals of Internal Medicine. ,vol. 120, pp. 834- 844 ,(1994) , 10.7326/0003-4819-120-10-199405150-00004
James A. Talcott, The Medical Course of Cancer Patients With Fever and Neutropenia Archives of Internal Medicine. ,vol. 148, pp. 2561- 2568 ,(1988) , 10.1001/ARCHINTE.1988.00380120031007
Kenneth V.I. Rolston, Edward B. Rubenstein, Alison Freifeld, EARLY EMPIRIC ANTIBIOTIC THERAPY FOR FEBRILE NEUTROPENIA PATIENTS AT LOW RISK Infectious Disease Clinics of North America. ,vol. 10, pp. 223- 237 ,(1996) , 10.1016/S0891-5520(05)70297-X
Linda S. Elting, Elias Anaissie, Kenneth Rolston, Nancy Khardori, Hagop Kantarjian, Carl Plager, William K. Murphy, Frankie Holmes, Fernando Cabanillas, Gerald P. Bodey, Victor Fainstein, β-Lactam regimens for the febrile neutropenic patient Cancer. ,vol. 65, pp. 9- 16 ,(1990) , 10.1002/1097-0142(19900101)65:1<9::AID-CNCR2820650105>3.0.CO;2-C
Lisa I. Iezzoni, Risk Adjustment for Measuring Healthcare Outcomes ,(1994)
Gerald P. Bodey, Overview of the problem of infections in the immunocompromised host The American Journal of Medicine. ,vol. 79, pp. 56- 61 ,(1985) , 10.1016/0002-9343(85)90129-9